Stats

Keyphrases

Publications

volume 7, number 2, 2024

Tong Si, Yunge Wang, Lingling Zhang, Evan Richmond, Tae-Hyuk Ahn, Haijun Gong
Multivariate Time Series Change-Point Detection with a Novel Pearson-like Scaled Bregman Divergence. Stats 7 (2) (2024)
Tong Si, Yunge Wang, Lingling Zhang, Evan Richmond, Tae-Hyuk Ahn, Haijun Gong
Multivariate Time Series Change-Point Detection with a Novel Pearson-like Scaled Bregman Divergence. Stats 7 (2) (2024)
Tong Si, Yunge Wang, Lingling Zhang, Evan Richmond, Tae-Hyuk Ahn, Haijun Gong
Multivariate Time Series Change-Point Detection with a Novel Pearson-like Scaled Bregman Divergence. Stats 7 (2) (2024)

volume 6, number 1, 2023

Fatema Shafie Khorassani, Jeremy M G Taylor, Niko Kaciroti, Michael R Elliott
Incorporating Covariates into Measures of Surrogate Paradox Risk. Stats 6 (1) (2023)

volume 6, number 2, 2023

Sixia Chen, Alexandra May Woodruff, Janis Campbell, Sara Vesely, Zheng Xu, Cuyler Snider
Combining Probability and Nonprobability Samples by Using Multivariate Mass Imputation Approaches with Application to Biomedical Research. Stats 6 (2) (2023)
Camden Bay, Robert J Glynn, Johanna M Seddon, Mei-Ling Ting Lee, Bernard Rosner
Evaluation of Risk Prediction with Hierarchical Data: Dependency Adjusted Confidence Intervals for the AUC. Stats 6 (2) (2023)

volume 5, number 2, 2022

Kellie J Archer, Anna Eames Seffernick, Shuai Sun, Yiran Zhang
ordinalbayes: Fitting Ordinal Bayesian Regression Models to High-Dimensional Data Using R. Stats 5 (2) (2022)
Sixia Chen, David Haziza, Zeinab Mashreghi
A Comparison of Existing Bootstrap Algorithms for Multi-Stage Sampling Designs. Stats 5 (2) (2022)
Sixia Chen, David Haziza, Zeinab Mashreghi
A Comparison of Existing Bootstrap Algorithms for Multi-Stage Sampling Designs. Stats 5 (2) (2022)
Sixia Chen, David Haziza, Zeinab Mashreghi
A Comparison of Existing Bootstrap Algorithms for Multi-Stage Sampling Designs. Stats 5 (2) (2022)

volume 3, number 3, 2020

Marcio Augusto Diniz, Sungjin Kim, Mourad Tighiouart
A Bayesian Adaptive Design in Cancer Phase I Trials Using Dose Combinations with Ordinal Toxicity Grades. Stats 3 (3) (2020)